Interlaboratory assessment of mitotic index by flow cytometry confirms superior reproducibility relative to microscopic scoring

Environmental and Molecular Mutagenesis

Volumn 53, Issue 4, 2012, Pages 297-303

  Roberts, D J ^a   Spellman, R A ^b   Sanok, K ^b   Chen, H ^a   Chan, M ^a,d   Yurt, P ^a   Thakur, A K ^a   Devito, G L ^b   Murli, H ^a   Stankowski, L F ^a,c  

^a Department of Environmental Air Quality   (United States)

^b PFIZER INC   (United States)

^c BioReliance Corporation   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Chromosome aberration assay; H3PS10; Histone; Human lymphocytes; Mitosis

Indexed keywords

ANTIBODY; BENZO[A]PYRENE; CYCLOPHOSPHAMIDE; ETOPOSIDE; HISTONE; MITOMYCIN C; NUCLEIC ACID;

ADULT; ARTICLE; CHROMOSOME ABERRATION; CYTOTOXICITY; FLOW CYTOMETRY; GENETIC TOXICOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTE; METAPHASE; MICROSCOPY; MITOSIS INDEX; REPRODUCIBILITY;

ADULT; BENZO(A)PYRENE; CHROMOSOME ABERRATIONS; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTES; MITOMYCIN; MITOTIC INDEX; REGRESSION ANALYSIS;

EID: 84862819580     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21684     Document Type: Article

References (14)

1. Bland, JM, Altman, DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet I: 307-310.
2. Galloway, SM. 2000. Cytotoxicity and chromosome aberrations in vitro: Experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ Mol Mutagen 35: 191-301.
3. ICH. 2011. Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use, ICH Harmonised Tripartite Guideline S2(R1).
4. King, HW, Thompson, MH Brookes, P. 1975. The benzo(alpha)pyrene deoxyribonucleoside products isolated from DNA after metabolism of benzo(alpha)pyrene by rat liver microsomes in the presence of DNA. Cancer Res 35: 1263-1269.
5. Linnet, K. 1998. Performance of deming regression analysis in case of misspecified analytical error ratio in method comparison studies. Clin Chem 44: 1024-1031.
6. Muehlbauer, PA, Schuler, MJ. 2003. Measuring the mitotic index in chemically-treated human lymphocyte cultures by flow cytometry. Mut Res 537: 117-130.
7. Muehlbauer, PA, Schuler, MJ. 2005. Detection of numerical chromosomal aberrations by flow cytometry: A novel process for identifying aneugenic agents. Mut Res 585: 156-169.
8. Muehlbauer, PA, Spellman, RA, Gunther, WC, Sanok, KE, Wiersch, CJ, O'Lone, SD, Dobo, KL, Schuler, MJ. 2008. Improving dose selection and identification of aneugens in the in vitro chromosome aberration test by integration of flow cytometry-based methods. EMM 49: 318-327.
9. OECD. 1997. In Vitro Mammalian Chromosome Aberration Test. OECD Guidelines for Testing of Chemicals, Section 4, Guideline 473.
10. Prigent, C. Dimitrov, S. 2003. Phosphorylation of serine 10 in histone H3, what for? J Cell Sci 116: 3677-3685.
11. Roberts, DJ, Middendorf, CA, Stojhovic, G., Roy, SK, Stankowski, LFJr, 2008a. Validation of flow cytometry to assess mitotic index in the human lymphocyte chromosome aberration assay. EMM 49: 575, Abstract.
12. Sieber, SM, Mead, JA and Adamson, RH 1976. Pharmacology of antitumor agents from higher plants. Cancer Treat Rep. 60: 1127-1139.
13. Xu, H., Lv, M., Tian, X. 2009. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007. Curr Med Chem 16: 327-349.
14. Yoshida, M., Usui, T., Tsujimura, K., Inagaki, M., Beppu, T., Horinouchi, S. 1997. Biochemical differences between staurosporine-induced apoptosis and premature mitosis. Exp Cell Res 232: 225-239.